Aligos Therapeutics Inc. is a clinical-stage biotechnology company that focuses on developing innovative medicines to treat viral diseases. With a particular focus on liver diseases caused by chronic hepatitis B virus (HBV) and hepatitis D virus (HDV) infections, the company aims to provide effective solutions for patients in need. Through its advanced research and development efforts, Aligos Therapeutics Inc. is revolutionizing the field of antiviral therapies.
Notification